Home
News
Create
Screeners
Insights
Kobo Biotech
8.
44
+0.16
(+1.93%)
Market Cap
₹20.08 Cr
PE Ratio
-3.76
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+1.93%
1M
+85.90%
6M
+237.60%
1Y
+223.37%
5Y
+63.57%
View Company Insights
Latest news about Kobo Biotech
Kobo Biotech loss widens to ₹5.23 crore in FY25
7 days ago
Kobo Biotech Limited reported a net loss of ₹5.23 crore for FY25, widening from ₹4.93 crore in the previous year, with no revenue from operations. The CIRP remains in effect, and the Resolution Plan by Beaufond Industries Limited was approved by NCLT.
Kobo Biotech narrows net loss to ₹49.29 lakh in FY 2023-24
7 days ago
NCLT Approves Beaufond Industries' Resolution Plan for Kobo Biotech Limited
May 13, 2026
Kobo Biotech Limited Submits SEBI Compliance Certificate for Quarter Ended March 31, 2026
Apr 15, 2026
Kobo Biotech Limited Confirms Non-Large Corporate Status Under SEBI Framework
Apr 15, 2026
More news about Kobo Biotech
31
Oct 25
Kobo Biotech Limited's Committee of Creditors Approves Multiple Resolutions, Including CIRP Extension and Professional Fees
Kobo Biotech Limited's Committee of Creditors (CoC) has approved several crucial resolutions in its ongoing Corporate Insolvency Resolution Process (CIRP). Key developments include the approval of CVK Technologies Private Limited's resolution plan, extension of CIRP period until January 29, and further extension for submission of resolution plans until April 15, 2025. The CoC also approved Resolution Professional fees, ratified various professional fees, and authorized the forfeiture of a Rs. 1.05 crore deposit from a previous applicant. JM Financial Asset Reconstruction Company Limited holds a 99.12% voting share in the CoC.
31
Oct 25
Kobo Biotech's Committee of Creditors Approves 90-Day Extension for Insolvency Resolution Process
Kobo Biotech Limited's Committee of Creditors (CoC) has approved a 90-day extension for the Corporate Insolvency Resolution Process, moving the deadline to May 14, 2025. The CoC also ratified expenses, appointed legal counsel, approved legal action against Telangana's Commercial Tax Department to recover Rs. 1.97 crores, and extended the timeline for resolution plan submissions to February 8, 2025. Namrata Randeri, the Resolution Professional, has been authorized to operate bank accounts and execute approved resolutions.
Kobo Biotech
8.
44
+
0.
16
(+
1.
93
%)
1 Year Returns:
+223.37%
Industry Peers
Deepak Fertilisers & Petrochemicals
1,605.20
(-
2.
67
%)
Tata Chemicals
696.15
(+
0.
44
%)
Gujarat Narmada Valley Fert & Chem
521.00
(-
1.
55
%)
TANFAC Industries
2,357.75
(-
2.
93
%)
Gujarat Alkalies & Chemicals
605.90
(-
0.
51
%)
GHCL
429.45
(-
0.
16
%)
Grauer & Weil
80.51
(-
3.
20
%)
Chemplast Sanmar
207.29
(-
0.
01
%)
Fischer Medical Ventures
37.92
(-
3.
49
%)
Thirumalai Chemicals
180.48
(-
1.
94
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar